Question

A 67-year-old with chronic kidney disease G3a and UACR 520 mg/g (A3) has type 2 diabetes controlled on metformin. Next disease-modifying kidney therapy?

Accepted Answer

Start an SGLT2 inhibitor (if eGFR ≥20 mL/min/1.73 m²)

Answer

Start a GLP-1 receptor agonist only

Answer

Start an ACE inhibitor only if UACR >1000 mg/g

Answer

Begin thiazide diuretic as monotherapy

Answer

No additional therapy is indicated

Practice question

A 67-year-old with chronic kidney disease G3a and UACR 520 mg/g (A3) has type 2 diabetes controlled on metformin. Next disease-modifying kidney therapy?